Skip to main content Skip to section navigation Skip to footer
Careers
Codexis, Inc. Corporate Page
  • About Us
    • Overview
    • Culture
    • Our People
    • Management Team
    • Board of Directors
    • Strategic Advisory Board
    • Sustainability
  • Services
    • Overview
    • Pharmaceutical Biocatalysis
    • RNA Manufacturing
  • Technology
    • CodeEvolver® Platform
    • ECO Synthesis™ Technology
  • Technical Content
  • Newsroom
    • Overview
    • In The News
    • Media Assets
  • Investors
    • Overview
    • News & Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • chevron_leftCareers

Access our TIDES USA 2025 Investor Recap Call

View Replay

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • TIDES US
  • Presentations
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • At-a-Glance
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Codexis Ethics Helpline
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • TIDES US
May 7, 2020 4:05 pm EDT
Codexis Reports First Quarter 2020 Financial Results
Read More
May 6, 2020 4:05 pm EDT
Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader
Read More
May 5, 2020 7:00 am EDT
Codexis Expands and Strengthens its Leadership Team with Two Executive Hires
Read More
Apr 30, 2020 7:00 am EDT
Codexis to Hold First Quarter 2020 Conference Call on May 7
Read More
Mar 23, 2020 7:00 am EDT
Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders
Read More
Feb 27, 2020 4:05 pm EST
Codexis Reports 2019 Fourth Quarter and Full Year Financial Results
Read More
Feb 25, 2020 7:00 am EST
Codexis to Present at Two Investment Conferences in March
Read More
Feb 20, 2020 7:00 am EST
Codexis to Hold 2019 Fourth Quarter and Full Year Conference Call on February 27
Read More
Jan 13, 2020 4:05 pm EST
Codexis Attends Opening Ceremony for Porton’s Fermentation Pilot Lab in Chongqing
Read More
Jan 10, 2020 7:00 am EST
Codexis and Nestlé Health Science Sign Development Agreement to Advance Therapeutic Candidate towards Clinical Studies and Extend Strategic Collaboration Agreement
Read More
  • Previous Pagechevron_left
  • Page 1
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • …
  • Page 26
  • Next Pagechevron_right
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed

Headquarters

200 Penobscot Drive
Redwood City, California
94063

Contact Us

©2025 Codexis, Inc. All Rights Reserved.
  • Sitemap
  • Terms of Sale
  • Trademarks
  • Terms of Use
  • Privacy
  • Accessibility Statement
  • Disclaimer
  • Patents
  • Events
  • Careers